GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » Cash Flow for Lease Financing

Delcath Systems (STU:DV3R) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Delcath Systems Cash Flow for Lease Financing?

Delcath Systems's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was €0.00 Mil. Delcath Systems's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2024 ), Delcath Systems's Cash Flow for Lease Financing remained the same in Mar. 2025 (€0.00 Mil).

Delcath Systems Cash Flow for Lease Financing Historical Data

The historical data trend for Delcath Systems's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Cash Flow for Lease Financing Chart

Delcath Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Delcath Systems Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Delcath Systems Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » Cash Flow for Lease Financing
Comparable Companies
AVNS NPCE BFLY TANAF CBLL KIDS AXGN BBNX SMLR RXST ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
DCTH:USA DV3R:Germany
Address
566 Queensbury Avenue, Queensbury, NY, USA, 12804
Website
https://www.delcath.com
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems Headlines

No Headlines